Cargando…

Clinically significant portal hypertension in cirrhosis patients with COVID-19: Clinical characteristics and outcomes

Detalles Bibliográficos
Autores principales:	Liu, Furong, Long, Xin, Ji, Guibao, Zhang, Bixiang, Zhang, Wanguang, Zhang, Zhanguo, Chen, Xiaoping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The British Infection Association. Published by Elsevier Ltd. 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834484/ https://www.ncbi.nlm.nih.gov/pubmed/32562796 http://dx.doi.org/10.1016/j.jinf.2020.06.029

Ejemplares similares

ACE2 Expression in Pancreas May Cause Pancreatic Damage After SARS-CoV-2 Infection
por: Liu, Furong, et al.
Publicado: (2020)

CA-125 Significance in Cirrhosis and Correlation with Disease Severity and Portal Hypertension
por: Collazos, Julio
Publicado: (2018)

Benefits of Splenectomy and Curative Treatments for Patients with Hepatocellular Carcinoma and Portal Hypertension: a Retrospective Study
por: Pei, Youliang, et al.
Publicado: (2018)

Flow Resistance Analysis of Clinically Significant Portal Hypertension in Patients with Liver Cirrhosis
por: Wang, Yizhe, et al.
Publicado: (2022)

Clinical characteristics of portal hypertension complicated by gastroesophageal varices in patients with my- eloproliferative neoplasms
por: Lee, Jaejun, et al.
Publicado: (2020)

Comment on “Hepatic-associated Immunoglobulin A Nephropathy in a Child with Liver Cirrhosis and Portal Hypertension”
por: Nasri, Hamid, et al.
Publicado: (2014)

The importance of N6-methyladenosine modification in tumor immunity and immunotherapy
por: Zhang, Ze, et al.
Publicado: (2022)

Differential Clinical Impact of Ascites in Cirrhosis and Idiopathic Portal Hypertension
por: Maruyama, Hitoshi, et al.
Publicado: (2015)

Helicobacter pylori infection and liver cirrhosis: possible association with hepatic encephalopathy and/or post-hepatic encephalopathy cognitive impairment in patients with portal hypertension
por: Kountouras, Jannis, et al.
Publicado: (2014)

The kidney in cirrhosis with portal hypertension
por: Olteanu, D, et al.
Publicado: (2010)

Severe Complications After Splenic Artery Embolization for Portal Hypertension Due to Hepatic Cirrhosis
por: Zhang, Lei, et al.
Publicado: (2020)

Development and validation of a radiomics signature for clinically significant portal hypertension in cirrhosis (CHESS1701): a prospective multicenter study
por: Liu, Fuquan, et al.
Publicado: (2018)

Prevalence of Arterial Hypertension in Cirrhosis of Liver
por: Prabhu P., Rajesh, et al.
Publicado: (2009)

Plasma Cyclic Guanosine Monophosphate Is a Promising Biomarker of Clinically Significant Portal Hypertension in Patients With Liver Cirrhosis
por: Sturm, Lukas, et al.
Publicado: (2022)

New Portal Vein Thrombosis in Cirrhosis - is the Thrombophilia Exacerbated due to Vaccine or COVID-19?
por: Premkumar, Madhumita, et al.
Publicado: (2022)

Hematological Indices in Portal Hypertension: Cirrhosis versus Noncirrhotic Portal Hypertension
por: Sahin, Abdurrahman, et al.
Publicado: (2018)

Ascitic Microbiota Composition Is Correlated with Clinical Severity in Cirrhosis with Portal Hypertension
por: Rogers, Geraint B., et al.
Publicado: (2013)

Portal hypertension complicating myelofibrosis in a patient without portal or hepatic vein thrombosis
por: Qi, Xingshun, et al.
Publicado: (2014)

Incomplete radiofrequency ablation provokes colorectal cancer liver metastases through heat shock response by PKCα/Fra-1 pathway
por: Zhang, Zhanguo, et al.
Publicado: (2019)

Hemodynamic alterations in cirrhosis and portal hypertension
por: Kim, Moon Young, et al.
Publicado: (2010)

Advances and challenges in cirrhosis and portal hypertension
por: Berzigotti, Annalisa
Publicado: (2017)

Tc99m sulfur colloid scintigraphy in differentiating noncirrhotic portal fibrosis from cirrhosis liver
por: Wiwanitkit, Viroj
Publicado: (2012)

Clinical Implications of the Serum Apelin Level on Portal Hypertension and Prognosis of Liver Cirrhosis
por: Lim, Yoo Li, et al.
Publicado: (2016)

Infrahepatic inferior vena cava clamping with Pringle maneuvers for laparoscopic extracapsular enucleation of giant liver hemangiomas
por: Zhang, Wanguang, et al.
Publicado: (2017)

Microenvironment characterization and multi-omics signatures related to prognosis and immunotherapy response of hepatocellular carcinoma
por: Liu, Furong, et al.
Publicado: (2020)

Helicobacter pylori and portal hypertensive gastropathy: any new information?
por: Zullo, Angelo, et al.
Publicado: (2014)

Peliosis hepatis complicated by portal hypertension following renal transplantation
por: Demyashkin, Grigory, et al.
Publicado: (2020)

Noninvasive predictors of clinically significant portal hypertension in NASH cirrhosis: Validation of ANTICIPATE models and development of a lab‐based model
por: Rabiee, Anahita, et al.
Publicado: (2022)

Transjugular intrahepatic portal shunt in the treatment of portal hypertension due to cirrhosis: single center experience
por: Chen, Yun, et al.
Publicado: (2019)

Surveillance for portal hypertension in the course of liver cirrhosis
por: Piekarska, Anna, et al.
Publicado: (2018)

Managing portal hypertension in patients with liver cirrhosis
por: Sauerbruch, Tilman, et al.
Publicado: (2018)

Extrapulmonary Sarcoidosis Manifested as Cirrhosis with Portal Hypertension
por: Kothakota, Sunil Raviraj, et al.
Publicado: (2021)

Portal hypertension in cirrhosis: Pathophysiological mechanisms and therapy
por: Iwakiri, Yasuko, et al.
Publicado: (2021)

Impact of clinically significant portal hypertension on surgical outcomes for hepatocellular carcinoma in patients with compensated liver cirrhosis: a propensity score matching analysis
por: Jang, Chul Woo, et al.
Publicado: (2016)

Hepatic von Meyenburg complex: a trigger of severe portal hypertension
por: Yoshida, Shuhei, et al.
Publicado: (2009)

CA-125 Significance in Cirrhosis and Correlation with Disease Severity and Portal Hypertension: A Retrospective Study
por: Edula, Raja GR, et al.
Publicado: (2018)

The impact of COVID-19 on the clinical outcome of patients with cirrhosis deserves more attention and research
por: Gao, Feng, et al.
Publicado: (2020)

A Narrative Review on Non-Cirrohotic Portal Hypertension: Not All Portal Hypertensions Mean Cirrhosis
por: Fiordaliso, Michele, et al.
Publicado: (2023)

Evaluating clinical outcomes and prognosis in patients with cirrhosis and portal hypertension: a retrospective observational cohort study
por: Lee, Nerissa Hoi Ching, et al.
Publicado: (2023)

von Willebrand factor as a biomarker of clinically significant portal hypertension and severe portal hypertension: a systematic review and meta-analysis
por: Zou, Ziyuan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_oiv21571s607g08r103jp66mi8